Triple-Negative Breast Cancer (TNBC) is an invasive type of breast carcinoma that lacks the expression of estrogen and progesteron receptor as well of the human epidermal growth factor receptor 2 (HER2) [111] and accounts from 10 to 15% of all BC [112]. Here, ERBB2 is linked to triple-negative breast carcinoma.